XML 52 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of stock options outstanding
 Options Outstanding    Options Exercisable 
 Range of
Exercise
Price
    Number
Outstanding at
December 31,
2021
    Weighted
Average
Remaining
Contractual Life
(Years)
    Weighted
Average
Exercise
Price
    Number
Exercisable at
December 31,
2021
    

Weighted
Average
Exercise
Price

 
$0.50    2,000,000    5.11   $0.50    2,000,000   $0.50 
 1.00 – 1.93    2,955,000    4.80    1.39    2,749,166    1.41 
 2.00 – 2.80    2,740,000    1.76    2.17    2,740,000    2.17 
 4.76    30,000    2.26    4.76    30,000    4.76 
$0.50 – 4.76    7,725,000    3.97   $1.45    7,519,166   $1.46 

 

Schedule of stock option activities
   Number of
Options
   Weighted
Average
Exercise
Price
 
Outstanding at January 1, 2020   5,260,000   $1.45 
Granted   1,960,000    1.52 
Expired   (80,000)   (1.00)
Outstanding at December 31, 2020   7,140,000    1.48 
Granted   860,000    1.08 
Forfeited / Expired   (275,000)   (1.01)
Outstanding at December 31, 2021   7,725,000   $1.45 
Options exercisable at December 31, 2021   7,519,166   $1.46 
Options expected to vest   205,834   $1.04 

 

Schedule of company’s nonvested stock options granted
   Number of
Options
   Weighted
Average
Exercise
Price
 
Nonvested at January 1, 2020   264,723   $2.00 
Granted   1,960,000    1.52 
Vested   (2,006,389)   (1.62)
Nonvested at December 31, 2020   218,334    1.18 
Granted   860,000    1.08 
Forfeited   (15,000)   (1.11)
Vested   (857,500)   (1.11)
Nonvested at December 31, 2021   205,834   $1.04